Researchers have proposed that wearable devices could be used to develop a network of health data about a patient, allowing for early diagnosis of COVID-19, even when the patient is asymptomatic.
Search for: pathogens
Artificial intelligence could help to optimise the development of antibody drugs. This leads to active substances with improved properties, also with regard to tolerability in the body.
Researchers have created life forms that self-assemble a body from single cells and do not require muscle cells to move. They're faster, live longer, and can now record information.
AI is helping researchers decipher images from a new holographic microscopy technique needed to investigate a key process in cancer immunotherapy “live” as it takes place.
Researchers have developed a unique inkjet printing method for fabricating tiny biocompatible polymer microdisk lasers for biosensing applications.
Professor Dr Peter Pott and his team turn to 3D printers to successfully realize his vision of “high end at low cost” medical devices.
An AI platform derives an optimal combination of available therapies against SARS-CoV-2 - the optimal drug therapy was a combination of the drugs remdesivir, ritonavir, and lopinavir at specific doses.
The following seven robotic systems are either currently being deployed or developed for the fight against the coronavirus.
Researchers have invented a high-throughput cell separation method that can be used in conjunction with droplet microfluidics.
Researchers at the Max Planck Institute for Intelligent Systems in Germany have developed powerful nanopropellers that can be steered into the interior of cells to deliver gene therapy.
Researchers have developed a ‘heater’ — about the size of a pill tablet — that regulates the temperature of biological samples through the different stages of diagnostic testing.
Researchers have developed a smart jumpsuit, or a garment that accurately measures the spontaneous and voluntary movement of infants from the age of five months.
Scientists have now produced tiny diamonds, so-called "nanodiamonds", which could serve as a platform for both the therapy and diagnosis of brain diseases.
The project “BioSensing” from Fraunhofer ISC aims to overcome the limits of modern biosensors with the help of quantum technology.
Research project is aimed at improving therapeutic options for both rare and common diseases, including supporting methods to improve editing the human genome.
"BactiCount" app and lab kit allow a smartphone to identify bacteria that cause urinary tract infections from patients anywhere in the world.